Annual report pursuant to Section 13 and 15(d)

QUARTERLY FINANCIAL DATA (Unaudited) (Tables)

v3.20.2
QUARTERLY FINANCIAL DATA (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of March 31,
    2019   2018   2017
ASSETS            
CURRENT ASSETS                        
Cash and cash equivalents   $ 4,166,517     $ 285,890     $ 63,244  
Accounts receivable     —         19,082       —    
Inventory     22,942       22,942       22,942  
Total Current Assets     4,189,459       327,914       86,186  
                         
PROPERTY AND EQUIPMENT, NET     1,706       1,706       1,706  
RIGHT-OF-USE ASSET     104,000       —         —    
INTANGIBLE ASSETS, NET     2,685,512       2,930,738       3,175,965  
DEBT ISSUANCE COSTS     —         —         —    
PRE-ACQUISITION COSTS     —         —         —    
DEPOSITS     5,253       5,253       5,253  
                         
TOTAL ASSETS   $ 6,985,930     $ 3,265,611     $ 3,269,110  
                         
                         
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable and accrued expenses   $ 3,916,364     $ 2,854,488     $ 2,837,354  
Accrued compensation and related liabilities     1,469,100       2,006,031       1,625,199  
Accrued interest     1,462,941       1,130,519       815,802  
Lease liabilities     104,000       —         —    
Notes payable     1,369,856       1,369,856       1,369,856  
Convertible notes payable     697,000       697,000       697,000  
Derivative liability     15,854,000       —         —    
Total Current Liabilities     24,873,261       8,057,894       7,345,211  
                         
LONG-TERM LIABILITIES                        
Convertible notes payable     1,000,000       —         —    
                         
TOTAL LIABILITIES     25,873,261       8,057,894       7,345,211  
                         
STOCKHOLDERS’ DEFICIT                        
Series A preferred stock     13       13       13  
Common stock     341,529       341,529       341,529  
Additional paid-in capital     30,712,228       30,610,179       30,599,931  
Accumulated deficit     (49,941,101 )     (35,744,004 )     (35,017,574 )
Total Stockholders' Deficit     (18,887,331 )     (4,792,283 )     (4,076,101 )
                         
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 6,985,930     $ 3,265,611     $ 3,269,110  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of March 31,
    2016
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 2,256  
Accounts receivable     13,595  
Inventory     25,921  
Other current assets     100,149  
Total Current Assets     141,921  
         
PROPERTY AND EQUIPMENT, NET     7,094  
RIGHT-OF-USE ASSET     —    
INTANGIBLE ASSETS, NET     3,421,191  
OTHER NONCURRENT ASSETS     2,626  
         
TOTAL ASSETS   $ 3,572,832  
         
         
LIABILITIES AND STOCKHOLDERS' DEFICIT        
CURRENT LIABILITIES        
Accounts payable and accrued expenses   $ 3,060,695  
Accrued compensation and related liabilities     1,435,216  
Accrued interest     528,573  
Notes payable     1,369,856  
Convertible notes payable     697,000  
Derivative liability     106,000  
Total Current Liabilities     7,197,340  
         
LONG-TERM LIABILITIES        
Accrued interest payable     —    
Accrued return on noncontrolling interest     —    
Mortgage notes payable     —    
Total Long-Term Liabilities     —    
         
STOCKHOLDERS' DEFICIT        
Series A preferred stock     13  
Common stock     341,405  
Additional paid-in capital     30,559,890  
Accumulated deficit     (34,629,719 )
Accumulated other comprehensive income     103,903  
Total Stockholders' Deficit     (3,624,508 )
         
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 3,572,832  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended March 31,
    2019   2018   2017
             
REVENUE   $ —       $ —       $ 50,334  
                         
OPERATING EXPENSES                        
General and administrative     1,027,577       126,664       216,869  
Amortization of intangible assets     61,307       61,307       61,307  
Preliminary stage acquisition costs     934,243       —         —    
Total Operating Expenses     2,023,127       187,971       278,176  
                         
OPERATING LOSS     (2,023,127 )     (187,971 )     (227,842 )
                         
OTHER INCOME (EXPENSE)                        
Other Income (Expense)     —         425,000       —    
Interest expense, net     (90,529 )     (80,631 )     (77,302 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance                        
charges related to derivative liability     (3,937,000 )     344,369       —    
Other Income (Expense), Net     (4,027,529 )     —         (77,302 )
                         
NET (LOSS)/INCOME   $ (6,050,656 )   $ 156,398     $ (305,144 )
                         
BASIC AND DILUTED LOSS PER COMMON SHARE:                        
Net Loss per Common Share   $ (0.02 )   $ 0.00     $ (0.00 )
                         
BASIC AND DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING     341,529,434       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended March 31,
    2016
     
REVENUE   $ 121,647  
         
OPERATING EXPENSES        
General and administrative     454,060  
Other operating     —    
Total Operating Expenses     454,060  
         
OPERATING LOSS     (332,413 )
         
OTHER INCOME (EXPENSE)        
Other Income (Expense)     (12,820 )
Interest expense, net     (73,517 )
Gain on settlement of liabilities     —    
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     —    
Total Other Income (Expense)     (86,337 )
         
NET LOSS   $ (418,750 )

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended March 31,
    2019   2018   2017
Operating Activities:                        
Net loss   $ (6,050,656 )   $ 156,398     $ (305,144 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     43,008       10,248       35,560  
Depreciation and amortization     61,306       61,307       61,307  
Change in fair value of derivative liability     3,397,000       —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         112,254  
Inventory     —         —         —    
Accounts payable and accrued expenses     858,863       (26,427 )     32,130  
Accrued compensation and related liabilities     (21 )     —         26,944  
Interest payable     90,528       80,631       78,029  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (1,059,972 )     282,157       41,080  
Investing Activities:                        
Pre-acquisition costs     —         —         —    
Cash received from derivative forward contract     —         —         —    
Net Cash Used in Investing Activities     —         —         —    
Financing Activities:                        
Debt issuance costs     —         —         —    
Proceeds from exercise of stock options     —         —         —    
Net Cash Used in Financing Activities     —         —         —    
                         
Net Change in Cash and Cash Equivalents     (1,059,972 )     282,157       41,080  
Cash and Cash Equivalents at Beginning of Period     5,226,489       3,733       22,164  
Cash and Cash Equivalents at End of Period   $ 4,166,517     $ 285,890     $ 63,244  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended March 31,
    2016
Operating Activities:        
Net loss   $ (418,750 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     —    
Share-based compensation     26,705  
Write-down of long-lived assets        
Depreciation and amortization     62,096  
Amortization of debt discount     —    
Change in fair value of derivative liability     —    
Changes in operating assets and liabilities:        
Accounts receivable     —    
Inventory     623  
Accounts payable and accrued expenses     150,185  
Accrued compensation and related liabilities     —    
Interest payable     —    
Other Operating Activities     —    
Other noncurrent assets     —    
Other current assets     (4,460 )
Net Cash Used in Operating Activities:     (183,601 )
Cash Flows of discontinued operations:        
Operating cash flows     153,758  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     153,758  
         
Effect of exchange rate changes on cash     (2,605 )
         
Net Change in Cash and Cash Equivalents     (32,448 )
Cash and Cash Equivalents at Beginning of Period     34,704  
Cash and Cash Equivalents at End of Period   $ 2,256  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of June 30,
    2019   2018   2017
ASSETS            
CURRENT ASSETS                        
Cash and cash equivalents   $ 2,275,500     $ 161,014     $ 64,978  
Accounts receivable     —         19,082       25,081  
Inventory     22,942       22,942       22,942  
Total Current Assets     2,298,442       203,038       113,001  
                         
PROPERTY AND EQUIPMENT, NET     1,706       1,706       1,706  
RIGHT-OF-USE ASSET     98,000       —         —    
INTANGIBLE ASSETS, NET     2,624,205       2,869,432       3,114,659  
DEBT ISSUANCE COSTS     100,000       —         —    
PRE-ACQUISITION COSTS     755,382       —         —    
DEPOSITS     505,253       5,253       5,253  
                         
TOTAL ASSETS   $ 6,382,988     $ 3,079,429     $ 3,234,619  
                         
                         
LIABILITIES AND STOCKHOLDERS' DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable and accrued expenses   $ 3,939,808     $ 2,808,299     $ 2,879,783  
Accrued compensation and related liabilities     1,469,100       2,003,482       1,652,143  
Accrued interest     1,553,470       1,211,150       967,545  
Lease liabilities     98,000       —         —    
Notes payable     1,369,856       1,369,856       1,369,856  
Convertible notes payable     697,000       697,000       697,000  
Derivative liability     14,536,000       —         —    
Total Current Liabilities     23,663,234       8,089,787       7,566,327  
                         
LONG-TERM LIABILITIES                        
Convertible notes payable     1,000,000       —         —    
                         
TOTAL LIABILITIES     24,663,234       8,089,787       7,566,327  
                         
STOCKHOLDERS' DEFICIT                        
Series A preferred stock     13       13       13  
Common stock     341,529       341,529       341,529  
Additional paid-in capital     31,179,041       30,669,220       30,599,931  
Accumulated deficit     (49,800,829 )     (36,021,120 )     (35,273,181 )
Total Stockholders' Deficit     (18,280,246 )     (5,010,358 )     (4,331,708 )
                         
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 6,382,988     $ 3,079,429     $ 3,234,619  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of June 30,
    2016
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 12,205  
Accounts receivable     62,924  
Inventory     24,431  
Other current assets     —    
Total Current Assets     99,560  
         
PROPERTY AND EQUIPMENT, NET     5,453  
RIGHT-OF-USE ASSET     —    
INTANGIBLE ASSETS, NET     3,359,885  
OTHER NONCURRENT ASSETS     2,626  
         
TOTAL ASSETS   $ 3,467,524  
         
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
CURRENT LIABILITIES        
Accounts payable and accrued expenses   $ 3,011,834  
Accrued compensation and related liabilities     1,228,969  
Accrued interest     633,173  
Notes Payable     1,369,856  
Convertible notes payable     697,000  
Derivative liability     —    
Total Current Liabilities     6,940,832  
         
LONG-TERM LIABILITIES        
Accrued interest payable     —    
Accrued return on non-controlling interest     —    
Mortgage notes payable     —    
Total Long-Term Liabilities     —    
         
TOTAL LIABILITIES        
      6,940,832  
STOCKHOLDERS’ DEFICIT        
Series A preferred stock     13  
Common stock     341,529  
Additional paid-in capital     30,564,371  
Accumulated deficit     (34,379,221 )
Accumulated other comprehensive income     —    
Total Stockholders' Deficit     (3,473,308 )
Noncontrolling interests     —    
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 3,467,524  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended June 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 109,539  
                         
Operating Expenses                        
General and Administrative     937,765       135,178       179,566  
Amortization of intangible assets     61,306       61,306       61,306  
Preliminary stage acquisition costs     82,693       —         —    
Total Operating Expenses     1,081,764       196,484       240,872  
                         
Operating Loss     (1,081,764 )     (196,484 )     (131,333 )
                         
Other Income (Expense)                        
Other Income (Expenses)     —         —         28,279  
Interest expense, net     (89,546 )     (80,632 )     (152,553 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance     —         —         —    
charges related to derivative liability     1,318,000       —         —    
Other Income (Expense), Net     1,228,454       (80,632 )     (124,274 )
                         
Net (Loss)/Income   $ 149,690     $ (277,116 )   $ (255,607 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share   $ (0.00 )   $ 0.00     $ (0.00 )
                         
Basic and diluted Weighted-Average Common Shares Outstanding     341,546,009       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended June 30,
    2016
     
Revenue   $ 79,583  
         
Operating Expenses     —    
General and Administrative     401,838  
Other Operating     —    
Total Operating Expenses     401,838  
         
Operating Loss     (322,255 )
         
Other Income (Expense)        
Other Income (Expense)     67,349  
Interest expense, net     (138,770 )
Gain on settlement of liabilities     537,612  
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     106,563  
Total Other Income (Expense), Net     572,753  
         
Loss from Continuing Operations     250,498  
         
Loss from Discontinued Operations     —    
         
Net (Loss)/Income   $ 250,498  
         
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the six months ended June 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 159,873  
                         
Operating Expenses                        
General and Administrative     1,065,342       261,842       396,434  
Amortization of intangible assets     122,613       122,613       122,613  
Preliminary stage acquisition costs     1,016,936       —         —    
Total Operating Expenses     3,104,891       384,455       519,047  
                         
Operating Loss     (3,104,891 )     (384,455 )     (359,174 )
                         
Other Income (Expense)                        
Other Income (Expense)     —         425,000       28,279  
Interest expense, net     (180,075 )     (161,263 )     (229,856 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance charges related to derivative liability     (2,619,000 )     —         —    
Other Income (Expense), Net     (2,799,075 )     263,737       (201,577 )
                         
Net Loss   $ (5,903,966 )   $ (120,718 )   $ (560,751 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share   $ (0.02 )   $ (0.00 )   $ (0.00 )
                         
Basic and diluted Weighted-Average Common Shares Outstanding     341,546,009       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the six months ended June 30,
    2016
     
Revenue   $ 201,230  
         
Operating Expenses        
General and Administrative     855,898  
Other operating     —    
Total Operating Expenses     855,899  
         
Operating Loss     (654,668 )
         
Other Income (Expense)        
Other Income (Expense)     54,528  
Interest expense, net     (212,287 )
Gain on settlement of liabilities     537,612  
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     105,563  
Total Other Income (Expense), Net     486,416  
         
Net Loss   $ (168,252 )
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,149,556  
         
Statement of Comprehensive Income        
Net Loss   $ (168,252 )
Other comprehensive loss-foreign currency translation adjustment     —    
Comprehensive Loss   $ (168,252 )

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended June 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ 146,690     $ (277,116 )   $ (255,607 )
Adjustments to reconcile net loss to net cash                        
 used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     460,395       59,041       —    
Depreciation and amortization     61,307       61,306       61,306  
Change in fair value of derivative liability     (1,318,000 )     —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         (25,081 )
Inventory     —         —         —    
Accounts payable and accrued expenses     23,444       (46,189 )     42,429  
Accrued compensation and related liabilities     —         (2,549 )     26,944  
Interest payable     90,529       80,631       151,743  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (535,635 )     (124,876 )     1,734  
Investing Activities:                        
Pre-acquisition costs and deposits     (1,255,382 )     —         —    
Cash received from derivative forward contract     —         —         —    
Net Cash Used in Investing Activities     (1,255,382 )     —         —    
Financing Activities:                        
Debt issuance costs     (100,000 )     —         —    
Proceeds from exercise of stock options     —         —         —    
Net Cash Used in Financing Activities     (100,000 )     —         —    
                         
Net change in Cash and Cash Equivalents     (1,891,017 )     (124,876 )     1,734  
Cash and Cash Equivalents at Beginning of Period     4,166,517       285,890       63,244  
Cash and Cash Equivalents at End of Period   $ 2,275,500     $ 161,014     $ 64,978  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended June 30,
    2016
Operating Activities:        
Net loss   $ 250,498  
Adjustments to reconcile net loss to net cash        
 used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     (255,752 )
Share-based compensation     4,606  
Write-down of long lived assets     —    
Depreciation and amortization     62,933  
Amortization of debt discount     —    
Change in fair value of derivative     (106,000 )
Changes in operating assets and liabilities:        
Accounts receivable     (52,764 )
Inventory     1,490  
Accounts payable and accrued expenses     (179,963 )
Accrued compensation and related liabilities     104,566  
Interest payable     178,144  
Other Operating Activities     —    
Other noncurrent assets     —    
Other current assets     41,306  
Net Cash Used in Operating Activities     49,063  
Investing Activities:        
Plantation developments costs        
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC     —    
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows     64,257  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     64,257  
         
Effect of exchange rate changes on cash     (103,371 )
         
Net change in Cash and Cash Equivalents     9,949  
Cash and Cash Equivalents at Beginning of Period     2,256  
Cash and Cash Equivalents at End of Period   $ 12,205  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the six months ended June 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ (5,903,966 )   $ (120,718 )   $ (560,751 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     503,403       69,289       35,560  
Depreciation and amortization     122,613       122,613       122,613  
Change in fair value of derivative liability     2,619,000       —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         87,173  
Inventory     —         —         —    
Accounts payable and accrued expenses     882,307       (72,616 )     74,559  
Accrued compensation and related liabilities     (21 )     (2,549 )     53,889  
Interest payable     181,057       161,262       229,771  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (1,595,607 )     157,281       42,814  
Investing Activities:                        
Pre-acquisition costs and deposits     (1,255,382 )     —         —    
Net Cash Used in Investing Activities     (1,255,382 )     —         —    
Financing Activities:                        
Debt issuance costs     (100,000 )     —         —    
Proceeds from exercise of stock options     —         —         —    
Net Cash Used in Financing Activities     (100,000 )     —         —    
                         
Net change in Cash and Cash Equivalents     (2,950,989 )     157,281       42,814  
Cash and Cash Equivalents at Beginning of Period     5,226,489       3,733       22,164  
Cash and Cash Equivalents at End of Period   $ 2,275,500     $ 161,014     $ 64,978  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the six months ended June 30,
    2016
Operating Activities:        
Net loss   $ (168,252 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     (255,752 )
Share-based compensation     31,311  
Depreciation and amortization     125,029  
Amortization of debt discount     —    
Change in fair value of derivative     (106,000 )
Changes in operating assets and liabilities:        
Accounts receivable     (52,764 )
Inventory     2,113  
Accounts payable and accrued expenses     (29,778 )
Accrued compensation and related liabilities     104,566  
Interest payable     178,144  
Other current assets     36,846  
Other noncurrent assets     —    
Net Cash Used in Operating Activities     (134,538 )
Investing Activities:        
Plantation developments costs     —    
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC     —    
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows     218,015  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     218,015  
         
Effect of exchange rate changes on cash     (105,976
         
Net change in Cash and Cash Equivalents     (22,499 )
Cash and Cash Equivalents at Beginning of Period     34,704  
Cash and Cash Equivalents at End of Period   $ 12,205  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of September 30,
    2019   2018   2017
ASSETS            
CURRENT ASSETS                        
Cash and cash equivalents   $ 217,214     $ 57,414     $ 70,996  
Accounts receivable     —         19,082       —    
Inventory     22,942       22,942       22,942  
Total Current Assets     240,156       99,438       93,938  
                         
PROPERTY AND EQUIPMENT, NET     1,706       1,706       1,706  
RIGHT-OF-USE ASSET     89,911       —         —    
INTANGIBLE ASSETS, NET     2,562,899       2,808,125       3,053,352  
DEBT ISSUANCE COSTS     250,000       —         —    
PRE-ACQUISITION COSTS     1,861,481       —         —    
DEPOSITS     1,005,253       5,253       5,253  
                         
TOTAL ASSETS   $ 6,011,406     $ 2,914,522     $ 3,154,249  
                         
                         
LIABILITIES AND STOCKHOLDERS' DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable and accrued expenses   $ 3,779,971     $ 2,832,289     $ 2,944,450  
Accrued compensation and related liabilities     1,469,100       2,003,482       1,679,087  
Accrued interest     1,643,998       1,291,782       1,008,717  
Lease liabilities     90,083       —         —    
Notes payable     1,369,856       1,369,856       1,369,856  
Convertible notes payable     1,697,000       697,000       697,000  
Derivative liability     14,130,000       —         —    
Total Current Liabilities     24,180,008       8,194,409       7,699,110  
                         
LONG-TERM LIABILITIES                        
Convertible notes payable     —         —         —    
                         
TOTAL LIABILITIES     24,180,008       8,194,409       7,699,110  
                         
STOCKHOLDERS' DEFICIT                        
Series A preferred stock     13       13       13  
Common stock     344,029       341,529       341,529  
Additional paid-in capital     31,216,468       30,669,220       30,599,931  
Accumulated deficit     (49,729,112 )     (36,290,649 )     (35,486,334 )
Total Stockholders' Deficit     (18,168,602 )     (5,279,887 )     (4544,861 )
                         
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 6,011,406     $ 2,914,522     $ 3,154,249  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of September 30,
    2016
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 17,179  
Accounts receivable     87,589  
Inventory     23,686  
Other current assets     —    
Total Current Assets     128,454  
         
PROPERTY AND EQUIPMENT, NET     3,812  
RIGHT-OF-USE ASSET     —    
INTANGIBLE ASSETS, NET     3,298,578  
OTHER NONCURRENT ASSETS     5,253  
         
TOTAL ASSETS   $ 3,436,097  
         
         
LIABILITIES AND STOCKHOLDERS' DEFICIT        
CURRENT LIABILITIES        
Accounts payable and accrued expenses   $ 2,917,748  
Accrued compensation and related liabilities     1,283,056  
Accrued interest     685,474  
Notes Payable     1,369,856  
Convertible notes payable     697,000  
Derivative liability     —    
Total Current Liabilities     6,953,134  
         
LONG-TERM LIABILITIES        
Accrued interest payable     —    
Accrued return on non-controlling interest     —    
Mortgage notes payable     —    
Total Long-Term Liabilities     6,953,134  
         
TOTAL LONG-TERM LIABILITIES     6,953,134  
         
STOCKHOLDERS' DEFICIT        
Series A preferred stock     13  
Common stock     341,529  
Additional paid-in capital     30,564,371  
Accumulated deficit     (34,422,950 )
Accumulated other comprehensive income     —    
Total Stockholders' Deficit     (3,517,037 )
Noncontrolling interests     —    
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 3,436,097  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended September 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 179,288  
                         
Operating Expenses                        
General and Administrative     126,509       127,591       289,158  
Amortization of intangible assets     61,307       61,307       61,307  
Preliminary stage acquisition costs     106,381       —         —    
Total Operating Expenses     294,197       188,898       350,465  
                         
Operating Loss     (294,197 )     (188,898 )     (171,177 )
                         
Other Income (Expense)                        
Other Income (Expense)     —         —         —    
Interest expense, net     (89,401 )     (80,631 )     (41,976 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance     —         —         —    
charges related to derivative liability     406,000       —         —    
Other Income (Expense), Net     316,599       (80,631 )     (41,976 )
                         
Net (Loss)/Income   $ 22,402       (269,529 )     (213,153 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share     (0.00 )     (0.00 )     (0.00 )
                 
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,434       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended September 30,
    2016
     
Revenue   $ 117,087  
         
Operating Expenses        
General and Administrative     150,299  
Other Operating     —    
Total Operating Expenses     150,299  
         
Operating Loss     (33,212 )
         
Other Income (Expense)        
Other Income (Expense)     3,635  
Interest expense, net     (14,152 )
Gain on settlement of liabilities     —    
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     —    
Total Other Income (Expense), Net     (10,517 )
         
Loss from Continuing Operations     (43,729 )
         
Loss from Discontinued Operations     —    
         
Net Loss   $ (43,729 )
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,454  
         
Statement of Comprehensive Income        
Net Loss   $ (43,729 )
Other comprehensive income (loss)-foreign currency translation adjustment     —    
Comprehensive Loss   $ (43,729 )

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the nine months ended September 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 339,161  
                         
Operating Expenses                        
General and Administrative     2,048,954       389,433       685,592  
Amortization of intangible assets     183,920       183,920       183,920  
Preliminary stage acquisition costs     1,123,317       —         —    
Total Operating Expenses     3,356,191       573,353       869,512  
                         
Operating Loss     (3,356,191 )     (573,353 )     (530,351 )
                         
Other Income (Expense)                        
Other Income (Expense)     —         425,000       28,279  
Interest expense, net     (269,476 )     (241,894 )     (271,832 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance     —         —         —    
charges related to derivative liability     (2,213,000 )     —         —    
Other Income (Expense), Net     (2,482,476 )     (183,106 )     (243,553 )
                         
Net Loss   $ (5,838,667 )   $ (390,247 )   $ (773,904 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share   $ (0.02 )   $ (0.00 )   $ (0.00 )
                         
Basic and diluted Weighted-Average Common Shares Outstanding     342,208,921       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the nine months ended September 30,
    2016
     
Revenue   $ 318,317  
         
Operating Expenses        
General and Administrative     1,006,197  
Other Operating     —    
Total Operating Expenses     1,006,197  
         
Operating Loss     (687,880 )
         
Other Income (Expense)        
Other Income (Expense)     58,163  
Interest expense, net     (226,439 )
Gain on settlement of liabilities     537,612  
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     106,563  
Total Other Income (Expense), Net     475,899  
         
Net Loss   $ (211,981 )
         
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,454  
         
         
Statement of Comprehensive Income        
Net Loss   $ (211,981 )
Other comprehensive income (loss)-foreign currency translation adjustment     —    
Comprehensive Loss   $ (211,981 )

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended September 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ 22,402     $ (269,529 )   $ (213,153 )
                         
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     71,742       —         —    
Depreciation and amortization     61,306       61,307       61,307  
Change in fair value of derivative liability     (406,000 )     —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         25,081  
Inventory     —         —         —    
Accounts payable and accrued expenses     (159,665 )     23,990       64,667  
Accrued compensation and related liabilities     —         —         26,944  
Interest payable     90,528       80,632       41,171  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (319,687 )     (103,600 )     6,018  
Investing Activities:                        
Pre-acquisition costs and deposits     (1,606,099 )     —         —    
Cash received from derivative forward contract     —         —         —    
Net Cash Used in Investing Activities     (1,606,099 )     —         —    
Financing Activities:                        
Debt issuance costs     (150,000 )     —         —    
Proceeds from exercise of stock options     17,500       —         —    
Net Cash Used in Financing Activities     132,500       —         —    
                         
Net change in Cash and Cash Equivalents     (2,058,286 )     (103,599 )     6,018  
Cash and Cash Equivalents at Beginning of Period     2,275,500       161,014       64,978  
Cash and Cash Equivalents at End of Period   $ 217,214     $ 57,415     $ 70,996  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended September 30,
    2016
Operating Activities:        
Net loss   $ (43,729 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     —    
Share-based compensation     —    
Write-down of long lived assets     —    
Loss on disposal of fixed assets     —    
Depreciation and amortization     62,947  
Amortization of debt discount     —    
Change in fair value of derivative     —    
Changes in operating assets and liabilities:        
Accounts receivable     (24,665 )
Inventory     (745 )
Accounts payable and accrued expenses     (94,086 )
Accrued compensation and related liabilities     54,087  
Interest payable     52,301  
Other Operating Activities     —    
Other current assets     (2,627 )
Other noncurrent assets     —    
Net Cash Used in Operating Activities     4,974  
Investing Activities:        
Plantation developments costs     —    
Proceeds from sale of property and equipment     —    
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC     —    
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows        
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     —    
         
Effect of exchange rate changes on cash     —    
         
Net Change in Cash and Cash Equivalents     4,974  
Cash and Cash Equivalents at Beginning of Period     12,205  
Cash and Cash Equivalents at End of Period   $ 17,179  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the nine months ended September 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ (5,881,564 )   $ (390,247 )   $ (773,904 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     575,145       69,289       35,560  
Depreciation and amortization     183,919       183,920       183,920  
Change in fair value of derivative liability     2,213,000       —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         112,254  
Inventory     —         —         —    
Accounts payable and accrued expenses     722,642       (48,626 )     139,226  
Accrued compensation and related liabilities     (21 )     (2,549 )     80,833  
Interest payable     271,585       241,894       270,943  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (1,915,294 )     53,681       48,832  
Investing Activities:                        
Pre-acquisition costs and deposits     (2,861,481 )                
Net Cash Used in Investing Activities     (2,861,481 )     —         —    
Financing Activities:                        
Debt issuance costs     (250,000 )                
Proceeds from exercise of stock options     17,500       —         —    
Net Cash Used in Financing Activities     (232,500 )     —         —    
                         
Net Change in Cash and Cash Equivalents     (5,009,275 )     53,681       48,832  
Cash and Cash Equivalents at Beginning of Period     5,226,489       3,733       22,164  
Cash and Cash Equivalents at End of Period   $ 217,214     $ 57,414     $ 70,996  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the nine months ended September 30,
    2016
Operating Activities:        
Net loss   $ (211,981 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     (255,752 )
Share-based compensation     31,311  
Write-down of long-lived assets     —    
Loss on disposal of fixed assets     —    
Depreciation and amortization     187,976  
Amortization of debt discount     —    
Change in fair value of derivative     (106,000 )
Changes in operating assets and liabilities:        
Accounts receivable     (77,429 )
Inventory     2,858  
Accounts payable and accrued expenses     (123,864 )
Accrued compensation and related liabilities     158,653  
Interest payable     230,445  
Other current assets     34,219  
Other noncurrent assets     —    
Net Cash Used in Operating Activities     (129,564 )
Investing Activities:        
Plantation developments costs     —    
Proceeds from sale of property and equipment     —    
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC        
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows     218,015  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     218,015  
         
Effect of exchange rate changes on cash     (105,976 )
         
Net Change in Cash and Cash Equivalents     (17,525 )
Cash and Cash Equivalents at Beginning of Period     34,704  
Cash and Cash Equivalents at End of Period   $ 17,179